GlassScriptPhysician profile
Brandon Michael Ishaque
NPI 1194085290
$6,473.53
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,360 · 2020: $442 · 2021: $891 · 2022: $2,476 · 2023: $930 · 2024: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,305.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,304.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,147.13 | 2021-2022 | |
| Medtronic USA, INC. | $1,790.38 | 2019-2020 | |
| Stryker Corporation | $1,247.52 | 2022-2023 | Optablate, Ivas |
| Sirtex Medical INC | $756.25 | 2023-2024 | Sir-Spheres Microspheres |
| Penumbra, INC. | $307.75 | 2022-2023 | Indigo System |
| Boston Scientific Corporation | $191.05 | 2021-2023 | Therasphere Y90 Glass Microspheres 10 Gbq |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22.22 | 2022 | |
| Medtronic Vascular, INC. | $11.23 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Ishaque listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.